Prognostic Markers in Peripheral Blood Shine Light on Future

Joseph Christopher Murray, MD, discusses the role of prognostic markers in non–small cell lung cancer and how data from the EMPOWER trials will guide future directions in the space.

Related Keywords

Maryland , United States , Baltimore , , Lung Cancer Precision Medicine Center , Johns Hopkins Sidney Kimmel Cancer Center , Nsclc , Non Small Cell Lung Cancer , Lung Cancer , Prognostic Markers , Peripheral Blood , Pasco , Asco Annual Meeting , Empower Lung3 , Peripheral Myeloid Cells , Cemiplimab Rwlc , Cemiplimab , Libtayo , Joseph Christopher Murray , D ,